In view of the dynamic and highly complex nature of the relation between leptin/ObR and glioma biology, combined multi-stage diagnostics have been recommended in order to appropriately distinguish, interpret and most importantly enhance the sensitivity/specificity ratio of serum sample analytics [37,38,39,40]. This evidence concerns the gene LEPR and central nervous system cancer.